EXOZ Sale Disclosure
Perriman Damien Alan · SEC Form 4 · Filed Oct 26, 2026
Sale
Calculated transaction value
$19.43K
Perriman Damien Alan Chief Commercial Officer
EXOZ
Exozymes Inc.
EXOZ
Transaction date
Oct 12, 2026
Public filing date
Oct 26, 2026
Filing lag
Filed 14 days later
EXOZ daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,729 shares @ $5.21
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001493152-26-048493
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$19.43K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Exozymes Inc. EXOZ Current | Sale | Oct 12, 2026 | $19.43K |
| Exozymes Inc. EXOZ | Exercise | Oct 9, 2026 | Not reported |
| Exozymes Inc. EXOZ | Exercise | Oct 9, 2026 | $0 |